B-QuiCK: Heart Failure

Log in
Choose another topic

Heart failure

Summary: Diagnosing patients with heart failure in primary care

Summary: Managing patients with heart failure in primary care

N.B. The approach of using an ACE inhibitor first-line before trialling an ARB (if the ACE inhibitor is contraindicated or not tolerated) is consistent with 2018 National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand Heart Failure guidelines. However, in the 2022 AHA/ACC/HFSA Heart Failure guidelines from the United States ACE inhibitors, ARBs and ARNIs are all now considered first-line options. It is possible that New Zealand guidance may change over time.

There are currently no comments for this article.

Please login to make a comment.

Made with by the bpacnz team

Partner links